/KURA

Kura Oncology Inc

KURA

$11.39USD↓-1.56%-0.18 today

MARKET CAP

1.0B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$11 – $12

52W RANGE

$7

$14

AI Summary

Stalk

StalkMedium

KURA remains in a constructive medium- and long-term uptrend but is undergoing a short-term pullback toward the 50-day SMA. No oversold or exhaustion signals are present, so new exposure is best deferred until price accepts support at the 50-day SMA and confirms resumed upside momentum.

↑Q2 2026 revenue $20.9M (+36% YoY); KOMZIFTI sales $9.1M (+57% QoQ)
↑$519M in cash/short-term investments funds operations to 2028 Phase 3 readout
↓Q2 net loss $68.3M; trailing 12-month net loss ~$296.8M

Full analysis →

Buying

5

institutions

Selling

7

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	10.51 M	115.29 M	+871.70 K	+47.1%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	3.13 M	34.30 M	+1.00 M	+98.6%	0.01%
RT Renaissance Technologies LLC Q2 2026	BUY	1.66 M	18.25 M	+81.20 K	+41.9%	0.03%
MM Millennium Management LLC Q2 2026	SELL	711.33 K	7.80 M	+-853.81 K	-38.7%	0.00%
FA Fisher Asset Management, LLC Q2 2026	SELL	625.94 K	6.87 M	+-49.37 K	+25.1%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	441.61 K	4.84 M	+-55.52 K	+19.9%	0.00%
MG Man Group Plc Q2 2026	SELL	432.91 K	4.75 M	+-42.12 K	+23.0%	0.01%
JC Jpmorgan Chase & Co Q2 2026	BUY	245.92 K	2.70 M	+193.35 K	+563.8%	0.00%
WP Woodline Partners LP Q2 2026	SELL	145.70 K	1.60 M	+-145.70 K	-32.5%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUY	49.84 K	404.98 K	+24.92 K	+56.5%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	27.23 K	298.76 K	+-57.34 K	-56.5%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	719.00	7.89 K	+-781.00	-35.3%	0.00%